An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 2, 2001, Pages 70-74

  Fleischer, Arthur C ^a   Wheeler, James E ^b   Lindsay, Iain ^c   Hendrix, Susan L ^d   Grabill, Scott ^e   Kravitz, Barbara ^e   MacDonald, Brian ^e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d HUTZEL HOSPITAL   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Endometrium; Hormone replacement therapy; Idoxifene; Transvaginal ultrasonography

Indexed keywords

IDOXIFENE;

ADENOCARCINOMA; ADULT; ARTICLE; ASPIRATION BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SCREENING; SYMPTOM; TRANSVAGINAL ECHOGRAPHY;

EID: 0035128733     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.111088     Document Type: Article

References (11)

1. Epidemiology of cancer of the endometrium
2. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities
3. Measuring the thickness - Is that what we have to do for sonographic assessment of the endometrium in postmenopausal women?
4. The behavior of endometrial hyperplasia. A long term study of "untreated" hyperplasia in 170 subjects
5. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease
6. Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality
7. Detection of occult endometrial carcinoma
8. Endomentrial morphology in asymptomatic post-menopausal women
9. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and post-menopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study)
10. Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies
11. Black-white differences in serum sex hormones and bone mineral density